November 22nd 2019
investor updates
November 13th 2019
press releases
November 7th 2019
press releases
November 1st 2019
press releases
November 1st 2019
press releases
November 1st 2019
press releases
Upcoming Events
Whats next.
January 13th 2020 - January 16th 2020
read more
February 19th 2020 - February 22nd 2020
read more
passion.
It takes a great deal of passion on the fight against cancer. We put our heart and soul into winning it.
know-how.
Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.
research.
Accurate research is the strong foundation for developing potential in effective treatment.
What is LAG3?
Lymphocyte-activation gene 3, or LAG-3 (LAG3), is a cell surface molecule with biologic effects on T cell function.
LAG3 is being used for many cancer immunotherapy treatments including Eftilagimod Alpha from Immutep.
